The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us
5137 Westlawn
Iowa City IA 52242
(319) 335-6660; fax (319) 384-4638

Release: Sept. 10, 2002

NOTE TO EDITORS: The following release originally was distributed July 15. Enrollment for the study is open until Sept. 30.

People with type 2 diabetes invited to participate in medication study

People who have had type 2 diabetes for six months or longer are invited to participate in a University of Iowa Health Care study of specific drug combinations to control blood sugar. The study will last approximately six months.

Eligible participants must be ages 18 to 79 and currently taking only metformin (Glucophage) or metformin extended release (Glucophage XR). In addition, women must not be pregnant, breastfeeding or planning to conceive while enrolled in the study.

The study will focus on comparing how well Glimepiride (Amaryl) or Pioglitazone (Actos) improve blood sugar control when either of them is added to drug treatment that already includes either Glucophage or GlucophageXR.

Potential participants will make an initial screening visit to determine eligibility. If a person is found eligible, participation in the study will require seven additional visits over an approximately 26-week period to UI Hospitals and Clinics. At the second visit, participants will randomly be assigned to take one of the two study medications, along with their other diabetes medication, for the remainder of the study period.

Participation will involve occasional fasting blood tests, EKG exams (heart tracing), physical exams, dietary and exercise instructions, and daily home blood sugar monitoring with recording of readings in a diary.

Diabetes medication, a blood glucose monitor and necessary supplies, as well as compensation for travel and participation, will be provided. In addition, all tests and examinations related to the study will be free of charge.

The study is being led by Udaya Kabadi, M.D., UI professor of internal medicine. The UI is one of 40 centers nationwide participating in the study.

For more information, contact Sheila Wayson, study coordinator, toll-free at (877) 807-9590 or locally at 356-4879 or by e-mail at

University of Iowa Health Care describes the partnership between the UI Roy J. and Lucille A. Carver College of Medicine and the UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide. Visit UI Health Care online at